MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.nucmedbio.2026.109844

Медицинская библиотека · Nuclear medicine and biology · 2026

Integrated [68Ga]Ga-FAPI-7ND PET/CT and stromal profiling of immunocompetent syngeneic tumor models for FAP-targeted radionuclide therapy.

Li Huijie, Zhang Yuling, Ren Xin, Liu Chenyue, Zhang Lexing, Wang Yuanbo, Qiang Wei, Jiao Shuai, Geng Qianqian, Gao Rui

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Most preclinical studies of fibroblast activation protein (FAP)-targeted radionuclide therapy (FAP-RNT) use immunodeficient xenografts, limiting evaluation within an intact immune microenvironment. This study aimed to characterized FAP-associated stromal and FAP inhibitor (FAPI) imaging phenotypes across immunocompetent syngeneic tumors and explored FAP-RNT effects in a representative model.

METHODS

Four syngeneic models (MC38, PAN02, LLC1, and 4 T1) were assessed using [68Ga]Ga-FAPI-7ND PET/CT, Western blotting, immunohistochemistry, and multiplex immunofluorescence for tracer uptake, FAP and α-SMA expression, and co-expression. Based on these findings, 4 T1-bearing mice underwent an exploratory therapeutic evaluation with saline or a single intravenous injection of [177Lu]Lu-FAPI-7ND. Tumor volume and body weight were measured every 2 days, and tumors were harvested on day 7 for histological and molecular analyses.

RESULTS

All models showed higher tumor uptake than contralateral muscle (all P < 0.05), with significant inter-model differences (P = 0.005) but comparable tumor-to-background ratios (P = 0.369). PAN02 had the highest uptake and enriched FAP+α-SMA+ stroma, whereas 4 T1 combined relatively high uptake with pronounced α-SMA-associated stromal activation. Because FAP-RNT response may reflect both tracer accumulation and stromal state, 4 T1 was selected for exploratory treatment. [177Lu]Lu-FAPI-7ND inhibited tumor growth (P < 0.0001) without significant body-weight loss. Treatment reduced CD8+ T-cell (P < 0.0001) and FOXP3+ regulatory T-cell densities (P = 0.012), did not alter their ratio (P = 0.537), and increased CD206-associated macrophage features (P < 0.05).

CONCLUSION

Syngeneic models exhibit distinct FAP-associated stromal and imaging phenotypes. In 4 T1 tumors, [177Lu]Lu-FAPI-7ND showed antitumor activity accompanied by immune microenvironmental alterations, supporting integrated model selection for immunocompetent FAP-RNT studies.

Для цитирования: Li Huijie, Zhang Yuling, Ren Xin, Liu Chenyue, Zhang Lexing, Wang Yuanbo, Qiang Wei, Jiao Shuai, Geng Qianqian, Gao Rui. Integrated [68Ga]Ga-FAPI-7ND PET/CT and stromal profiling of immunocompetent syngeneic tumor models for FAP-targeted radionuclide therapy.. Nuclear medicine and biology. 2026. DOI: 10.1016/j.nucmedbio.2026.109844.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.